Replies to post #250211 on Elite Pharmaceuticals Inc (ELTP)

[dr_lowenstein]

Elite Pharmaceutical is also a DISASTER.

agreed

[NASDAQ2020]

I'm glad SequestOx will be the FIRST IR opiod with AD Oral Labeling
Oral Labeling is the Holy Grail in the pain market

SequestOx™ will receive ORAL, Nasal and IV ADF labeling
Inspirion's lost big not getting oral AD labeling
SequestOx will make their product obsolete by years end.
Reformulated SequestOx™ with lowered fed Tmax is now the SAFEST Immediate Release opiod in the world, and the only one using a Pharmalogical Approach to abuse deterrence.
To date there have been no adverse events with Elites SequestOx™,
This is what Congress, President, FDA and the Public are looking for.
Perfect storm for Elite, right place-right time

SequestOx™ Elite's market disruptive ADF labeled Immediate Release opiod
can not be abused by:

NASAL:
Insuffalation/snorting all particle sizes

IV:
injecting/IV/poor syringe ability

Smoking:

ORAL:
chewing
crushing/mechanical manipulation
grating
milling
sucking
splitting
breaking
grinding
use with alcohol
sandpapering
blended
melting
microwave
baking
freezing
extracting
centrifuging
bead separation
difficult to defeat with common solvents

ELTP


The Pharacological Approach gets all three labeling .

[dr_lowenstein]

Back to reality

Coll market cap $290M

eltp market cap $130 M



wheeeeeeeeeeeee

[jour_trader]

Stock decrease has coincided with equity offerings. Half of company's 300M valuation is from 150M in the bank.

Here is info about Collegium's Xtampza: UnitedHealth will make Xtampza exclusive from Q1 onwards, at the expense of OxyContin.

Xtampza is expected to bring in 50M or 1% of potential market by end of 2017. Company burns 100M cash per year so plenty of expense to cut if sales don't materialize.

Xtampza ramp rate of scrips is eye opener for those that think SequestOx will "own" markets overnight. Not a chance.